Prostaglandin J2

Drug Profile

Prostaglandin J2

Alternative Names: PGJ2

Latest Information Update: 23 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University of Rome
  • Developer Cayman Chemical; University of Rome
  • Class Antineoplastics; Prostaglandins
  • Mechanism of Action Prostaglandin D agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 21 Aug 1998 Profile reviewed
  • 11 Nov 1994 Preclinical development for Cancer in Italy (Unknown route)
  • 11 Nov 1994 Preclinical development for Cancer in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top